TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
hsa05202	Transcriptional misregulation in cancer	0.00145443307032911	-6.53313909667449	179	5	0.151515151515152	33	6908	5087,6935,51384,2115,5468	PBX1,ZEB1,WNT16,ETV1,PPARG
ko05202	Transcriptional misregulation in cancer	0.00145443307032911	-6.53313909667449	179	5	0.151515151515152	33	6908	5087,6935,51384,2115,5468	PBX1,ZEB1,WNT16,ETV1,PPARG
hsa04512	ECM-receptor interaction	0.00801524604482116	-4.82640979534798	87	3	0.0909090909090909	33	6908	3910,3691,960	LAMA4,ITGB4,CD44
ko04512	ECM-receptor interaction	0.00801524604482116	-4.82640979534798	87	3	0.0909090909090909	33	6908	3910,3691,960	LAMA4,ITGB4,CD44
ko00230	Purine metabolism	0.00899754597463459	-4.71080340831205	174	4	0.121212121212121	33	6908	5631,10846,5139,4907	PRPS1,PDE10A,PDE3A,NT5E
hsa00230	Purine metabolism	0.00899754597463459	-4.71080340831205	174	4	0.121212121212121	33	6908	10846,5631,5139,4907	PDE10A,PRPS1,PDE3A,NT5E
hsa05032	Morphine addiction	0.00906858015885482	-4.70293956968305	91	3	0.0909090909090909	33	6908	54331,10846,5139	GNG2,PDE10A,PDE3A
ko05032	Morphine addiction	0.00906858015885482	-4.70293956968305	91	3	0.0909090909090909	33	6908	54331,10846,5139	GNG2,PDE10A,PDE3A
ko04713	Circadian entrainment	0.010199709454946	-4.58539604390682	95	3	0.0909090909090909	33	6908	54331,6262,817	GNG2,RYR2,CAMK2D
hsa04713	Circadian entrainment	0.010199709454946	-4.58539604390682	95	3	0.0909090909090909	33	6908	54331,6262,817	GNG2,RYR2,CAMK2D
hsa04340	Hedgehog signaling pathway	0.024387771463476	-3.71367344184008	51	2	0.0606060606060606	33	6908	7546,51384	ZIC2,WNT16
ko04340	Hedgehog signaling pathway	0.024387771463476	-3.71367344184008	51	2	0.0606060606060606	33	6908	7546,51384	ZIC2,WNT16
hsa05200	Pathways in cancer	0.0384019454964577	-3.25964715670158	397	5	0.151515151515152	33	6908	3910,54331,2254,51384,5468	LAMA4,GNG2,FGF9,WNT16,PPARG
ko03320	PPAR signaling pathway	0.0425535801965127	-3.15699128657378	69	2	0.0606060606060606	33	6908	5468,51129	PPARG,ANGPTL4
hsa03320	PPAR signaling pathway	0.0425535801965127	-3.15699128657378	69	2	0.0606060606060606	33	6908	5468,51129	PPARG,ANGPTL4
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.048278153476259	-3.03077612962632	74	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.048278153476259	-3.03077612962632	74	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
ko05206	MicroRNAs in cancer	0.0514158087568717	-2.96780959044567	297	4	0.121212121212121	33	6908	6935,7431,960,4325	ZEB1,VIM,CD44,MMP16
hsa05206	MicroRNAs in cancer	0.0514158087568717	-2.96780959044567	297	4	0.121212121212121	33	6908	6935,7431,960,4325	ZEB1,VIM,CD44,MMP16
ko05410	Hypertrophic cardiomyopathy (HCM)	0.0592413031205944	-2.82613629251532	83	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
hsa05410	Hypertrophic cardiomyopathy (HCM)	0.0592413031205944	-2.82613629251532	83	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
hsa04911	Insulin secretion	0.0617856624500199	-2.78408394062508	85	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa05222	Small cell lung cancer	0.0630718944169708	-2.76348002202117	86	2	0.0606060606060606	33	6908	3910,317	LAMA4,APAF1
ko05222	Small cell lung cancer	0.0630718944169708	-2.76348002202117	86	2	0.0606060606060606	33	6908	3910,317	LAMA4,APAF1
ko05414	Dilated cardiomyopathy	0.0669854577590502	-2.70327973152196	89	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
hsa05414	Dilated cardiomyopathy	0.0669854577590502	-2.70327973152196	89	2	0.0606060606060606	33	6908	6262,3691	RYR2,ITGB4
ko04024	cAMP signaling pathway	0.068298072636696	-2.68387373188561	199	3	0.0909090909090909	33	6908	6262,817,5139	RYR2,CAMK2D,PDE3A
hsa04024	cAMP signaling pathway	0.068298072636696	-2.68387373188561	199	3	0.0909090909090909	33	6908	6262,817,5139	RYR2,CAMK2D,PDE3A
hsa05205	Proteoglycans in cancer	0.071604768653858	-2.63659360592244	203	3	0.0909090909090909	33	6908	817,51384,960	CAMK2D,WNT16,CD44
ko05205	Proteoglycans in cancer	0.071604768653858	-2.63659360592244	203	3	0.0909090909090909	33	6908	817,51384,960	CAMK2D,WNT16,CD44
hsa04151	PI3K-Akt signaling pathway	0.0807412783883465	-2.51650533028727	346	4	0.121212121212121	33	6908	3910,54331,2254,3691	LAMA4,GNG2,FGF9,ITGB4
ko04151	PI3K-Akt signaling pathway	0.0807412783883465	-2.51650533028727	346	4	0.121212121212121	33	6908	3910,54331,2254,3691	LAMA4,GNG2,FGF9,ITGB4
hsa04916	Melanogenesis	0.0819975612501315	-2.50106577301221	100	2	0.0606060606060606	33	6908	817,51384	CAMK2D,WNT16
ko04916	Melanogenesis	0.0819975612501315	-2.50106577301221	100	2	0.0606060606060606	33	6908	817,51384	CAMK2D,WNT16
hsa04725	Cholinergic synapse	0.0979461489808516	-2.32333745153752	111	2	0.0606060606060606	33	6908	54331,817	GNG2,CAMK2D
hsa04114	Oocyte meiosis	0.0994379162346625	-2.30822178700062	112	2	0.0606060606060606	33	6908	817,9748	CAMK2D,SLK
ko04114	Oocyte meiosis	0.0994379162346625	-2.30822178700062	112	2	0.0606060606060606	33	6908	817,9748	CAMK2D,SLK
hsa04360	Axon guidance	0.122552912676795	-2.09921240203794	127	2	0.0606060606060606	33	6908	223117,1948	SEMA3D,EFNB2
ko04360	Axon guidance	0.122552912676795	-2.09921240203794	127	2	0.0606060606060606	33	6908	223117,1948	SEMA3D,EFNB2
hsa05166	HTLV-I infection	0.12390521823572	-2.08823837472286	258	3	0.0909090909090909	33	6908	4488,4487,51384	MSX2,MSX1,WNT16
ko05166	HTLV-I infection	0.12390521823572	-2.08823837472286	258	3	0.0909090909090909	33	6908	4488,4487,51384	MSX2,MSX1,WNT16
ko04728	Dopaminergic synapse	0.125730635941914	-2.07361347039323	129	2	0.0606060606060606	33	6908	54331,817	GNG2,CAMK2D
hsa04728	Dopaminergic synapse	0.125730635941914	-2.07361347039323	129	2	0.0606060606060606	33	6908	54331,817	GNG2,CAMK2D
ko05216	Thyroid cancer	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	5468	PPARG
ko00030	Pentose phosphate pathway	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	5631	PRPS1
ko00760	Nicotinate and nicotinamide metabolism	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	4907	NT5E
hsa00030	Pentose phosphate pathway	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	5631	PRPS1
hsa00760	Nicotinate and nicotinamide metabolism	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	4907	NT5E
hsa05216	Thyroid cancer	0.129902385560818	-2.04097199087976	29	1	0.0303030303030303	33	6908	5468	PPARG
hsa04310	Wnt signaling pathway	0.145203027905397	-1.92962232346591	141	2	0.0606060606060606	33	6908	817,51384	CAMK2D,WNT16
ko04310	Wnt signaling pathway	0.145203027905397	-1.92962232346591	141	2	0.0606060606060606	33	6908	817,51384	CAMK2D,WNT16
hsa04550	Signaling pathways regulating pluripotency of stem cells	0.146854618387464	-1.91831217213872	142	2	0.0606060606060606	33	6908	51384,6926	WNT16,TBX3
ko04550	Signaling pathways regulating pluripotency of stem cells	0.146854618387464	-1.91831217213872	142	2	0.0606060606060606	33	6908	51384,6926	WNT16,TBX3
ko05143	African trypanosomiasis	0.150579261290652	-1.89326568033224	34	1	0.0303030303030303	33	6908	3910	LAMA4
hsa05143	African trypanosomiasis	0.150579261290652	-1.89326568033224	34	1	0.0303030303030303	33	6908	3910	LAMA4
ko04261	Adrenergic signaling in cardiomyocytes	0.156847559953793	-1.852480901025	148	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa04261	Adrenergic signaling in cardiomyocytes	0.156847559953793	-1.852480901025	148	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa05330	Allograft rejection	0.162755827321148	-1.81550419318178	37	1	0.0303030303030303	33	6908	5551	PRF1
ko05330	Allograft rejection	0.162755827321148	-1.81550419318178	37	1	0.0303030303030303	33	6908	5551	PRF1
ko04921	Oxytocin signaling pathway	0.172079554740588	-1.75979838154003	157	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa04921	Oxytocin signaling pathway	0.172079554740588	-1.75979838154003	157	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
ko05332	Graft-versus-host disease	0.17872823099392	-1.72188888947377	41	1	0.0303030303030303	33	6908	5551	PRF1
hsa05332	Graft-versus-host disease	0.17872823099392	-1.72188888947377	41	1	0.0303030303030303	33	6908	5551	PRF1
hsa04940	Type I diabetes mellitus	0.186603230856969	-1.67877067637276	43	1	0.0303030303030303	33	6908	5551	PRF1
ko04940	Type I diabetes mellitus	0.186603230856969	-1.67877067637276	43	1	0.0303030303030303	33	6908	5551	PRF1
ko05152	Tuberculosis	0.206747371821678	-1.57625765702526	177	2	0.0606060606060606	33	6908	817,317	CAMK2D,APAF1
hsa05152	Tuberculosis	0.206747371821678	-1.57625765702526	177	2	0.0606060606060606	33	6908	817,317	CAMK2D,APAF1
ko04020	Calcium signaling pathway	0.210262348546997	-1.55939924916889	179	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa04020	Calcium signaling pathway	0.210262348546997	-1.55939924916889	179	2	0.0606060606060606	33	6908	6262,817	RYR2,CAMK2D
hsa04978	Mineral absorption	0.217377355458746	-1.52612047044347	51	1	0.0303030303030303	33	6908	30061	SLC40A1
hsa05014	Amyotrophic lateral sclerosis (ALS)	0.217377355458746	-1.52612047044347	51	1	0.0303030303030303	33	6908	317	APAF1
ko04978	Mineral absorption	0.217377355458746	-1.52612047044347	51	1	0.0303030303030303	33	6908	30061	SLC40A1
ko05014	Amyotrophic lateral sclerosis (ALS)	0.217377355458746	-1.52612047044347	51	1	0.0303030303030303	33	6908	317	APAF1
hsa05320	Autoimmune thyroid disease	0.221143805398998	-1.50894208591701	52	1	0.0303030303030303	33	6908	5551	PRF1
ko05320	Autoimmune thyroid disease	0.221143805398998	-1.50894208591701	52	1	0.0303030303030303	33	6908	5551	PRF1
ko05016	Huntington's disease	0.224387246504846	-1.49438194070607	187	2	0.0606060606060606	33	6908	317,5468	APAF1,PPARG
hsa05016	Huntington's disease	0.224387246504846	-1.49438194070607	187	2	0.0606060606060606	33	6908	317,5468	APAF1,PPARG
hsa05134	Legionellosis	0.232337994705466	-1.4595620937963	55	1	0.0303030303030303	33	6908	317	APAF1
ko05217	Basal cell carcinoma	0.232337994705466	-1.4595620937963	55	1	0.0303030303030303	33	6908	51384	WNT16
ko05134	Legionellosis	0.232337994705466	-1.4595620937963	55	1	0.0303030303030303	33	6908	317	APAF1
hsa05217	Basal cell carcinoma	0.232337994705466	-1.4595620937963	55	1	0.0303030303030303	33	6908	51384	WNT16
hsa05416	Viral myocarditis	0.243376101786574	-1.41314728818518	58	1	0.0303030303030303	33	6908	5551	PRF1
ko05169	Epstein-Barr virus infection	0.245723936449336	-1.40354658275395	199	2	0.0606060606060606	33	6908	7431,960	VIM,CD44
hsa05169	Epstein-Barr virus infection	0.245723936449336	-1.40354658275395	199	2	0.0606060606060606	33	6908	7431,960	VIM,CD44
ko00561	Glycerolipid metabolism	0.247021151224718	-1.39828131353168	59	1	0.0303030303030303	33	6908	84803	GPAT3
hsa00561	Glycerolipid metabolism	0.247021151224718	-1.39828131353168	59	1	0.0303030303030303	33	6908	84803	GPAT3
hsa04510	Focal adhesion	0.260011613316454	-1.34702898236239	207	2	0.0606060606060606	33	6908	3910,3691	LAMA4,ITGB4
ko04510	Focal adhesion	0.260011613316454	-1.34702898236239	207	2	0.0606060606060606	33	6908	3910,3691	LAMA4,ITGB4
ko04721	Synaptic vesicle cycle	0.261431813688852	-1.34158178019039	63	1	0.0303030303030303	33	6908	23025	UNC13A
hsa04721	Synaptic vesicle cycle	0.261431813688852	-1.34158178019039	63	1	0.0303030303030303	33	6908	23025	UNC13A
hsa04924	Renin secretion	0.264992478428597	-1.32805383668704	64	1	0.0303030303030303	33	6908	5139	PDE3A
ko04924	Renin secretion	0.264992478428597	-1.32805383668704	64	1	0.0303030303030303	33	6908	5139	PDE3A
hsa05131	Shigellosis	0.264992478428597	-1.32805383668704	64	1	0.0303030303030303	33	6908	960	CD44
hsa05214	Glioma	0.26853649482213	-1.31476845314441	65	1	0.0303030303030303	33	6908	817	CAMK2D
ko05214	Glioma	0.26853649482213	-1.31476845314441	65	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04720	Long-term potentiation	0.27206393829497	-1.3017181730492	66	1	0.0303030303030303	33	6908	817	CAMK2D
ko04720	Long-term potentiation	0.27206393829497	-1.3017181730492	66	1	0.0303030303030303	33	6908	817	CAMK2D
ko04810	Regulation of actin cytoskeleton	0.272533487146974	-1.29999378381628	214	2	0.0606060606060606	33	6908	2254,3691	FGF9,ITGB4
hsa04810	Regulation of actin cytoskeleton	0.272533487146974	-1.29999378381628	214	2	0.0606060606060606	33	6908	2254,3691	FGF9,ITGB4
hsa05031	Amphetamine addiction	0.275574883933929	-1.28889587631064	67	1	0.0303030303030303	33	6908	817	CAMK2D
ko05031	Amphetamine addiction	0.275574883933929	-1.28889587631064	67	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04115	p53 signaling pathway	0.279069406488143	-1.27629475932389	68	1	0.0303030303030303	33	6908	317	APAF1
ko04115	p53 signaling pathway	0.279069406488143	-1.27629475932389	68	1	0.0303030303030303	33	6908	317	APAF1
hsa04622	RIG-I-like receptor signaling pathway	0.286009479784479	-1.25173032261203	70	1	0.0303030303030303	33	6908	10010	TANK
ko04622	RIG-I-like receptor signaling pathway	0.286009479784479	-1.25173032261203	70	1	0.0303030303030303	33	6908	10010	TANK
hsa05218	Melanoma	0.289455178404881	-1.23975481811834	71	1	0.0303030303030303	33	6908	2254	FGF9
ko05218	Melanoma	0.289455178404881	-1.23975481811834	71	1	0.0303030303030303	33	6908	2254	FGF9
hsa04014	Ras signaling pathway	0.295788143099092	-1.2181118136904	227	2	0.0606060606060606	33	6908	54331,2254	GNG2,FGF9
hsa01230	Biosynthesis of amino acids	0.296298266880249	-1.21638867362577	73	1	0.0303030303030303	33	6908	5631	PRPS1
ko01230	Biosynthesis of amino acids	0.296298266880249	-1.21638867362577	73	1	0.0303030303030303	33	6908	5631	PRPS1
ko04260	Cardiac muscle contraction	0.299695802676776	-1.20498730984009	74	1	0.0303030303030303	33	6908	6262	RYR2
hsa04971	Gastric acid secretion	0.299695802676776	-1.20498730984009	74	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04260	Cardiac muscle contraction	0.299695802676776	-1.20498730984009	74	1	0.0303030303030303	33	6908	6262	RYR2
ko04971	Gastric acid secretion	0.299695802676776	-1.20498730984009	74	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04925	Aldosterone synthesis and secretion	0.323037124928175	-1.1299880245062	81	1	0.0303030303030303	33	6908	817	CAMK2D
ko04925	Aldosterone synthesis and secretion	0.323037124928175	-1.1299880245062	81	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04210	Apoptosis	0.336034434522949	-1.09054164057077	85	1	0.0303030303030303	33	6908	317	APAF1
ko04210	Apoptosis	0.336034434522949	-1.09054164057077	85	1	0.0303030303030303	33	6908	317	APAF1
hsa04012	ErbB signaling pathway	0.342442019149758	-1.07165292276454	87	1	0.0303030303030303	33	6908	817	CAMK2D
ko04640	Hematopoietic cell lineage	0.342442019149758	-1.07165292276454	87	1	0.0303030303030303	33	6908	960	CD44
ko04012	ErbB signaling pathway	0.342442019149758	-1.07165292276454	87	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04640	Hematopoietic cell lineage	0.342442019149758	-1.07165292276454	87	1	0.0303030303030303	33	6908	960	CD44
hsa04727	GABAergic synapse	0.34562328484858	-1.06240586918127	88	1	0.0303030303030303	33	6908	54331	GNG2
ko04727	GABAergic synapse	0.34562328484858	-1.06240586918127	88	1	0.0303030303030303	33	6908	54331	GNG2
ko04912	GnRH signaling pathway	0.355077792539288	-1.03541837959956	91	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04912	GnRH signaling pathway	0.355077792539288	-1.03541837959956	91	1	0.0303030303030303	33	6908	817	CAMK2D
hsa00564	Glycerophospholipid metabolism	0.367477974766232	-1.00109189473417	95	1	0.0303030303030303	33	6908	84803	GPAT3
ko04972	Pancreatic secretion	0.367477974766232	-1.00109189473417	95	1	0.0303030303030303	33	6908	6262	RYR2
hsa04972	Pancreatic secretion	0.367477974766232	-1.00109189473417	95	1	0.0303030303030303	33	6908	6262	RYR2
ko00564	Glycerophospholipid metabolism	0.367477974766232	-1.00109189473417	95	1	0.0303030303030303	33	6908	84803	GPAT3
hsa04750	Inflammatory mediator regulation of TRP channels	0.376626068859335	-0.97650244354211	98	1	0.0303030303030303	33	6908	817	CAMK2D
ko04750	Inflammatory mediator regulation of TRP channels	0.376626068859335	-0.97650244354211	98	1	0.0303030303030303	33	6908	817	CAMK2D
ko04922	Glucagon signaling pathway	0.385645808119265	-0.952835926311754	101	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04922	Glucagon signaling pathway	0.385645808119265	-0.952835926311754	101	1	0.0303030303030303	33	6908	817	CAMK2D
ko04723	Retrograde endocannabinoid signaling	0.385645808119265	-0.952835926311754	101	1	0.0303030303030303	33	6908	54331	GNG2
hsa04723	Retrograde endocannabinoid signaling	0.385645808119265	-0.952835926311754	101	1	0.0303030303030303	33	6908	54331	GNG2
hsa04066	HIF-1 signaling pathway	0.391588522262877	-0.937543678604974	103	1	0.0303030303030303	33	6908	817	CAMK2D
hsa00240	Pyrimidine metabolism	0.394538937953045	-0.93003744153133	104	1	0.0303030303030303	33	6908	4907	NT5E
ko00240	Pyrimidine metabolism	0.394538937953045	-0.93003744153133	104	1	0.0303030303030303	33	6908	4907	NT5E
hsa05146	Amoebiasis	0.403307180784703	-0.908056772191392	107	1	0.0303030303030303	33	6908	3910	LAMA4
ko05146	Amoebiasis	0.403307180784703	-0.908056772191392	107	1	0.0303030303030303	33	6908	3910	LAMA4
hsa04726	Serotonergic synapse	0.417647998608154	-0.873116309822941	112	1	0.0303030303030303	33	6908	54331	GNG2
ko01200	Carbon metabolism	0.420475782009075	-0.866368394547373	113	1	0.0303030303030303	33	6908	5631	PRPS1
hsa01200	Carbon metabolism	0.420475782009075	-0.866368394547373	113	1	0.0303030303030303	33	6908	5631	PRPS1
ko04724	Glutamatergic synapse	0.423290248408774	-0.859697168789423	114	1	0.0303030303030303	33	6908	54331	GNG2
hsa04724	Glutamatergic synapse	0.423290248408774	-0.859697168789423	114	1	0.0303030303030303	33	6908	54331	GNG2
hsa05145	Toxoplasmosis	0.434416155188894	-0.833752321392571	118	1	0.0303030303030303	33	6908	3910	LAMA4
ko05145	Toxoplasmosis	0.434416155188894	-0.833752321392571	118	1	0.0303030303030303	33	6908	3910	LAMA4
ko04722	Neurotrophin signaling pathway	0.439900773685092	-0.82120609185408	120	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04722	Neurotrophin signaling pathway	0.439900773685092	-0.82120609185408	120	1	0.0303030303030303	33	6908	817	CAMK2D
hsa04152	AMPK signaling pathway	0.448031118615506	-0.802892587784143	123	1	0.0303030303030303	33	6908	5468	PPARG
ko04152	AMPK signaling pathway	0.448031118615506	-0.802892587784143	123	1	0.0303030303030303	33	6908	5468	PPARG
hsa05012	Parkinson's disease	0.463949891009574	-0.767978726101451	129	1	0.0303030303030303	33	6908	317	APAF1
hsa04380	Osteoclast differentiation	0.469156527917667	-0.756818817992105	131	1	0.0303030303030303	33	6908	5468	PPARG
ko04380	Osteoclast differentiation	0.469156527917667	-0.756818817992105	131	1	0.0303030303030303	33	6908	5468	PPARG
hsa04650	Natural killer cell mediated cytotoxicity	0.476874647395735	-0.740501616349748	134	1	0.0303030303030303	33	6908	5551	PRF1
ko04650	Natural killer cell mediated cytotoxicity	0.476874647395735	-0.740501616349748	134	1	0.0303030303030303	33	6908	5551	PRF1
hsa05161	Hepatitis B	0.506673269393454	-0.67988892219723	146	1	0.0303030303030303	33	6908	317	APAF1
hsa04390	Hippo signaling pathway	0.525617436872532	-0.64318163718597	154	1	0.0303030303030303	33	6908	51384	WNT16
ko04390	Hippo signaling pathway	0.525617436872532	-0.64318163718597	154	1	0.0303030303030303	33	6908	51384	WNT16
hsa05010	Alzheimer's disease	0.543855352260296	-0.609071964063297	162	1	0.0303030303030303	33	6908	317	APAF1
ko05010	Alzheimer's disease	0.543855352260296	-0.609071964063297	162	1	0.0303030303030303	33	6908	317	APAF1
hsa04022	cGMP-PKG signaling pathway	0.554906790190621	-0.588955124942629	167	1	0.0303030303030303	33	6908	5139	PDE3A
ko04022	cGMP-PKG signaling pathway	0.554906790190621	-0.588955124942629	167	1	0.0303030303030303	33	6908	5139	PDE3A
ko05034	Alcoholism	0.580381382754332	-0.544069835064218	179	1	0.0303030303030303	33	6908	54331	GNG2
hsa05034	Alcoholism	0.580381382754332	-0.544069835064218	179	1	0.0303030303030303	33	6908	54331	GNG2
ko04062	Chemokine signaling pathway	0.59657280651421	-0.516553988707655	187	1	0.0303030303030303	33	6908	54331	GNG2
hsa04062	Chemokine signaling pathway	0.59657280651421	-0.516553988707655	187	1	0.0303030303030303	33	6908	54331	GNG2
hsa01130	Biosynthesis of antibiotics	0.639820649908699	-0.446567376419108	210	1	0.0303030303030303	33	6908	5631	PRPS1
hsa04015	Rap1 signaling pathway	0.641595197319696	-0.443797707932138	211	1	0.0303030303030303	33	6908	2254	FGF9
ko04015	Rap1 signaling pathway	0.641595197319696	-0.443797707932138	211	1	0.0303030303030303	33	6908	2254	FGF9
hsa04010	MAPK signaling pathway	0.711812565175712	-0.339940653384537	255	1	0.0303030303030303	33	6908	2254	FGF9
ko04010	MAPK signaling pathway	0.711812565175712	-0.339940653384537	255	1	0.0303030303030303	33	6908	2254	FGF9
hsa04060	Cytokine-cytokine receptor interaction	0.725801519288208	-0.32047869094522	265	1	0.0303030303030303	33	6908	27242	TNFRSF21
ko04060	Cytokine-cytokine receptor interaction	0.725801519288208	-0.32047869094522	265	1	0.0303030303030303	33	6908	27242	TNFRSF21
hsa04740	Olfactory transduction	0.863773332197871	-0.146444891590279	404	1	0.0303030303030303	33	6908	817	CAMK2D
ko04740	Olfactory transduction	0.863773332197871	-0.146444891590279	404	1	0.0303030303030303	33	6908	817	CAMK2D
hsa01100	Metabolic pathways	0.945976480171918	-0.0555375726368828	1214	3	0.0909090909090909	33	6908	5631,84803,4907	PRPS1,GPAT3,NT5E
hsa00770	Pantothenate and CoA biosynthesis	0.999999999977998	-2.20020878564851e-11	18	0	0	33	6908
ko00770	Pantothenate and CoA biosynthesis	0.999999999977998	-2.20020878564851e-11	18	0	0	33	6908
hsa00511	Other glycan degradation	0.999999999977998	-2.20020878564851e-11	18	0	0	33	6908
ko00511	Other glycan degradation	0.999999999977998	-2.20020878564851e-11	18	0	0	33	6908
hsa03450	Non-homologous end-joining	0.999999999980715	-1.92848022944141e-11	13	0	0	33	6908
hsa00061	Fatty acid biosynthesis	0.999999999980715	-1.92848022944141e-11	13	0	0	33	6908
ko03450	Non-homologous end-joining	0.999999999980715	-1.92848022944141e-11	13	0	0	33	6908
ko00061	Fatty acid biosynthesis	0.999999999980715	-1.92848022944141e-11	13	0	0	33	6908
ko00052	Galactose metabolism	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
hsa05310	Asthma	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
ko00020	Citrate cycle (TCA cycle)	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
hsa00052	Galactose metabolism	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
hsa00020	Citrate cycle (TCA cycle)	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
ko05310	Asthma	0.999999999981376	-1.86235983175797e-11	30	0	0	33	6908
hsa04110	Cell cycle	0.999999999982065	-1.79349095591138e-11	124	0	0	33	6908
ko04110	Cell cycle	0.999999999982065	-1.79349095591138e-11	124	0	0	33	6908
ko03410	Base excision repair	0.999999999982907	-1.70933675623578e-11	33	0	0	33	6908
hsa03410	Base excision repair	0.999999999982907	-1.70933675623578e-11	33	0	0	33	6908
hsa04540	Gap junction	0.999999999983178	-1.68222906643124e-11	88	0	0	33	6908
ko04540	Gap junction	0.999999999983178	-1.68222906643124e-11	88	0	0	33	6908
ko00330	Arginine and proline metabolism	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
hsa05144	Malaria	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
ko00510	N-Glycan biosynthesis	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
hsa00330	Arginine and proline metabolism	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
hsa00510	N-Glycan biosynthesis	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
ko05144	Malaria	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
hsa05030	Cocaine addiction	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
ko05030	Cocaine addiction	0.999999999984481	-1.55193809934741e-11	49	0	0	33	6908
ko05231	Choline metabolism in cancer	0.999999999984991	-1.50087326562838e-11	101	0	0	33	6908
hsa05231	Choline metabolism in cancer	0.999999999984991	-1.50087326562838e-11	101	0	0	33	6908
hsa00591	Linoleic acid metabolism	0.999999999985733	-1.4266575740418e-11	29	0	0	33	6908
hsa03440	Homologous recombination	0.999999999985733	-1.4266575740418e-11	29	0	0	33	6908
ko03440	Homologous recombination	0.999999999985733	-1.4266575740418e-11	29	0	0	33	6908
ko00591	Linoleic acid metabolism	0.999999999985733	-1.4266575740418e-11	29	0	0	33	6908
ko05033	Nicotine addiction	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
ko00380	Tryptophan metabolism	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
hsa05033	Nicotine addiction	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
ko00620	Pyruvate metabolism	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
hsa00620	Pyruvate metabolism	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
hsa00380	Tryptophan metabolism	0.999999999986788	-1.32119359318374e-11	40	0	0	33	6908
ko04130	SNARE interactions in vesicular transport	0.999999999986872	-1.31285202650309e-11	34	0	0	33	6908
hsa04130	SNARE interactions in vesicular transport	0.999999999986872	-1.31285202650309e-11	34	0	0	33	6908
ko00740	Riboflavin metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
hsa00290	Valine, leucine and isoleucine biosynthesis	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
ko00471	D-Glutamine and D-glutamate metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
hsa00471	D-Glutamine and D-glutamate metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
hsa00740	Riboflavin metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
ko00290	Valine, leucine and isoleucine biosynthesis	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
hsa00730	Thiamine metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
ko00730	Thiamine metabolism	0.999999999986881	-1.31188040338748e-11	4	0	0	33	6908
ko00140	Steroid hormone biosynthesis	0.999999999986905	-1.30950101140012e-11	58	0	0	33	6908
hsa00140	Steroid hormone biosynthesis	0.999999999986905	-1.30950101140012e-11	58	0	0	33	6908
hsa04150	mTOR signaling pathway	0.999999999987064	-1.29359772821215e-11	60	0	0	33	6908
ko04150	mTOR signaling pathway	0.999999999987064	-1.29359772821215e-11	60	0	0	33	6908
hsa04730	Long-term depression	0.999999999987064	-1.29359772821215e-11	60	0	0	33	6908
ko04730	Long-term depression	0.999999999987064	-1.29359772821215e-11	60	0	0	33	6908
ko00232	Caffeine metabolism	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
hsa00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
hsa00524	Butirosin and neomycin biosynthesis	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
ko00524	Butirosin and neomycin biosynthesis	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
hsa00232	Caffeine metabolism	0.999999999987407	-1.25928194343172e-11	5	0	0	33	6908
hsa04913	Ovarian steroidogenesis	0.999999999987719	-1.22804783212191e-11	50	0	0	33	6908
ko04913	Ovarian steroidogenesis	0.999999999987719	-1.22804783212191e-11	50	0	0	33	6908
ko04915	Estrogen signaling pathway	0.999999999988057	-1.1943291270524e-11	99	0	0	33	6908
hsa04915	Estrogen signaling pathway	0.999999999988057	-1.1943291270524e-11	99	0	0	33	6908
ko00350	Tyrosine metabolism	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
ko05020	Prion diseases	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
hsa00350	Tyrosine metabolism	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
hsa00250	Alanine, aspartate and glutamate metabolism	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
hsa05020	Prion diseases	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
ko00250	Alanine, aspartate and glutamate metabolism	0.99999999998823	-1.17701172767204e-11	35	0	0	33	6908
ko00514	Other types of O-glycan biosynthesis	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa04710	Circadian rhythm	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
ko04710	Circadian rhythm	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
ko00512	Mucin type O-Glycan biosynthesis	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa00512	Mucin type O-Glycan biosynthesis	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa00514	Other types of O-glycan biosynthesis	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
ko00410	beta-Alanine metabolism	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
ko03020	RNA polymerase	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa03020	RNA polymerase	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa00410	beta-Alanine metabolism	0.999999999988277	-1.172266370071e-11	31	0	0	33	6908
hsa00300	Lysine biosynthesis	0.999999999988537	-1.14632061709672e-11	2	0	0	33	6908
ko00300	Lysine biosynthesis	0.999999999988537	-1.14632061709672e-11	2	0	0	33	6908
ko04620	Toll-like receptor signaling pathway	0.999999999988752	-1.12480772824268e-11	106	0	0	33	6908
hsa04620	Toll-like receptor signaling pathway	0.999999999988752	-1.12480772824268e-11	106	0	0	33	6908
hsa04070	Phosphatidylinositol signaling system	0.999999999989173	-1.08273916314966e-11	98	0	0	33	6908
ko04070	Phosphatidylinositol signaling system	0.999999999989173	-1.08273916314966e-11	98	0	0	33	6908
hsa00310	Lysine degradation	0.999999999989281	-1.07186691727253e-11	52	0	0	33	6908
hsa05213	Endometrial cancer	0.999999999989281	-1.07186691727253e-11	52	0	0	33	6908
ko00310	Lysine degradation	0.999999999989281	-1.07186691727253e-11	52	0	0	33	6908
ko05213	Endometrial cancer	0.999999999989281	-1.07186691727253e-11	52	0	0	33	6908
hsa04141	Protein processing in endoplasmic reticulum	0.99999999998963	-1.03695554408824e-11	168	0	0	33	6908
ko04141	Protein processing in endoplasmic reticulum	0.99999999998963	-1.03695554408824e-11	168	0	0	33	6908
ko04744	Phototransduction	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
hsa00630	Glyoxylate and dicarboxylate metabolism	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
ko00640	Propanoate metabolism	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
hsa04744	Phototransduction	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
hsa00640	Propanoate metabolism	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
ko00630	Glyoxylate and dicarboxylate metabolism	0.999999999990139	-9.86130627555851e-12	28	0	0	33	6908
ko04973	Carbohydrate digestion and absorption	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
ko00565	Ether lipid metabolism	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
hsa00565	Ether lipid metabolism	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
hsa04973	Carbohydrate digestion and absorption	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
hsa03022	Basal transcription factors	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
ko03022	Basal transcription factors	0.999999999990398	-9.60229680503706e-12	45	0	0	33	6908
hsa00460	Cyanoamino acid metabolism	0.999999999990437	-9.56274093759643e-12	7	0	0	33	6908
ko00460	Cyanoamino acid metabolism	0.999999999990437	-9.56274093759643e-12	7	0	0	33	6908
ko00790	Folate biosynthesis	0.999999999990777	-9.2230063946518e-12	14	0	0	33	6908
hsa00790	Folate biosynthesis	0.999999999990777	-9.2230063946518e-12	14	0	0	33	6908
hsa00603	Glycosphingolipid biosynthesis - globo series	0.999999999990777	-9.2230063946518e-12	14	0	0	33	6908
ko00603	Glycosphingolipid biosynthesis - globo series	0.999999999990777	-9.2230063946518e-12	14	0	0	33	6908
ko05132	Salmonella infection	0.999999999990784	-9.21626699317753e-12	85	0	0	33	6908
hsa05132	Salmonella infection	0.999999999990784	-9.21626699317753e-12	85	0	0	33	6908
hsa05164	Influenza A	0.999999999990917	-9.08250509072697e-12	174	0	0	33	6908
ko05164	Influenza A	0.999999999990917	-9.08250509072697e-12	174	0	0	33	6908
ko04120	Ubiquitin mediated proteolysis	0.99999999999096	-9.04036390754242e-12	137	0	0	33	6908
hsa04120	Ubiquitin mediated proteolysis	0.99999999999096	-9.04036390754242e-12	137	0	0	33	6908
ko00900	Terpenoid backbone biosynthesis	0.999999999990983	-9.01746699327585e-12	22	0	0	33	6908
hsa00900	Terpenoid backbone biosynthesis	0.999999999990983	-9.01746699327585e-12	22	0	0	33	6908
hsa05223	Non-small cell lung cancer	0.999999999991135	-8.8650569843269e-12	56	0	0	33	6908
ko00500	Starch and sucrose metabolism	0.999999999991135	-8.8650569843269e-12	56	0	0	33	6908
hsa00500	Starch and sucrose metabolism	0.999999999991135	-8.8650569843269e-12	56	0	0	33	6908
ko05223	Non-small cell lung cancer	0.999999999991135	-8.8650569843269e-12	56	0	0	33	6908
hsa04923	Regulation of lipolysis in adipocytes	0.999999999991135	-8.8650569843269e-12	56	0	0	33	6908
hsa04975	Fat digestion and absorption	0.999999999991583	-8.41717008791686e-12	41	0	0	33	6908
ko05219	Bladder cancer	0.999999999991583	-8.41717008791686e-12	41	0	0	33	6908
ko04975	Fat digestion and absorption	0.999999999991583	-8.41717008791686e-12	41	0	0	33	6908
hsa05219	Bladder cancer	0.999999999991583	-8.41717008791686e-12	41	0	0	33	6908
ko00860	Porphyrin and chlorophyll metabolism	0.99999999999177	-8.2301601457094e-12	42	0	0	33	6908
hsa00860	Porphyrin and chlorophyll metabolism	0.99999999999177	-8.2301601457094e-12	42	0	0	33	6908
ko05133	Pertussis	0.999999999992011	-7.98928099124631e-12	75	0	0	33	6908
hsa05133	Pertussis	0.999999999992011	-7.98928099124631e-12	75	0	0	33	6908
ko03040	Spliceosome	0.999999999992119	-7.88112521030931e-12	132	0	0	33	6908
hsa03040	Spliceosome	0.999999999992119	-7.88112521030931e-12	132	0	0	33	6908
hsa02010	ABC transporters	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko00071	Fatty acid degradation	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko02010	ABC transporters	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
hsa03050	Proteasome	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko04962	Vasopressin-regulated water reabsorption	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
hsa00071	Fatty acid degradation	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
hsa00970	Aminoacyl-tRNA biosynthesis	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
hsa04962	Vasopressin-regulated water reabsorption	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko03050	Proteasome	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko00970	Aminoacyl-tRNA biosynthesis	0.999999999992135	-7.86502158878192e-12	44	0	0	33	6908
ko04666	Fc gamma R-mediated phagocytosis	0.999999999992262	-7.73759414383252e-12	92	0	0	33	6908
hsa04666	Fc gamma R-mediated phagocytosis	0.999999999992262	-7.73759414383252e-12	92	0	0	33	6908
ko05130	Pathogenic Escherichia coli infection	0.999999999992325	-7.67534253058066e-12	55	0	0	33	6908
hsa05150	Staphylococcus aureus infection	0.999999999992325	-7.67534253058066e-12	55	0	0	33	6908
ko05150	Staphylococcus aureus infection	0.999999999992325	-7.67534253058066e-12	55	0	0	33	6908
hsa05130	Pathogenic Escherichia coli infection	0.999999999992325	-7.67534253058066e-12	55	0	0	33	6908
ko04140	Regulation of autophagy	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
ko04960	Aldosterone-regulated sodium reabsorption	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
hsa04140	Regulation of autophagy	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
ko00260	Glycine, serine and threonine metabolism	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
hsa00260	Glycine, serine and threonine metabolism	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
hsa04960	Aldosterone-regulated sodium reabsorption	0.999999999992522	-7.47815785981719e-12	39	0	0	33	6908
ko04610	Complement and coagulation cascades	0.999999999992642	-7.35754320264772e-12	69	0	0	33	6908
hsa04610	Complement and coagulation cascades	0.999999999992642	-7.35754320264772e-12	69	0	0	33	6908
hsa00270	Cysteine and methionine metabolism	0.999999999992779	-7.22100528172034e-12	37	0	0	33	6908
ko00270	Cysteine and methionine metabolism	0.999999999992779	-7.22100528172034e-12	37	0	0	33	6908
ko04370	VEGF signaling pathway	0.999999999992901	-7.09897972305518e-12	61	0	0	33	6908
hsa04370	VEGF signaling pathway	0.999999999992901	-7.09897972305518e-12	61	0	0	33	6908
hsa00190	Oxidative phosphorylation	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
hsa04270	Vascular smooth muscle contraction	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
ko04270	Vascular smooth muscle contraction	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
ko04071	Sphingolipid signaling pathway	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
hsa04071	Sphingolipid signaling pathway	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
ko00190	Oxidative phosphorylation	0.999999999992953	-7.04723269416873e-12	120	0	0	33	6908
ko05160	Hepatitis C	0.999999999993079	-6.92088979179076e-12	133	0	0	33	6908
hsa03010	Ribosome	0.999999999993079	-6.92088979179076e-12	133	0	0	33	6908
ko03010	Ribosome	0.999999999993079	-6.92088979179076e-12	133	0	0	33	6908
hsa05160	Hepatitis C	0.999999999993079	-6.92088979179076e-12	133	0	0	33	6908
ko04670	Leukocyte transendothelial migration	0.999999999993164	-6.83634693200023e-12	118	0	0	33	6908
hsa04670	Leukocyte transendothelial migration	0.999999999993164	-6.83634693200023e-12	118	0	0	33	6908
hsa04919	Thyroid hormone signaling pathway	0.999999999993164	-6.83634693200023e-12	118	0	0	33	6908
hsa04612	Antigen processing and presentation	0.999999999993219	-6.78056006918274e-12	77	0	0	33	6908
ko03018	RNA degradation	0.999999999993219	-6.78056006918274e-12	77	0	0	33	6908
ko04612	Antigen processing and presentation	0.999999999993219	-6.78056006918274e-12	77	0	0	33	6908
hsa03018	RNA degradation	0.999999999993219	-6.78056006918274e-12	77	0	0	33	6908
hsa00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
ko00592	alpha-Linolenic acid metabolism	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
hsa00592	alpha-Linolenic acid metabolism	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
hsa00062	Fatty acid elongation	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
ko00062	Fatty acid elongation	0.999999999993225	-6.77536847197865e-12	25	0	0	33	6908
hsa00980	Metabolism of xenobiotics by cytochrome P450	0.999999999993274	-6.7263880599768e-12	74	0	0	33	6908
ko00980	Metabolism of xenobiotics by cytochrome P450	0.999999999993274	-6.7263880599768e-12	74	0	0	33	6908
hsa00910	Nitrogen metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
hsa00450	Selenocompound metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko00120	Primary bile acid biosynthesis	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko01210	2-Oxocarboxylic acid metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
hsa00360	Phenylalanine metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
hsa01210	2-Oxocarboxylic acid metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko00360	Phenylalanine metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko00910	Nitrogen metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko00450	Selenocompound metabolism	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
hsa00120	Primary bile acid biosynthesis	0.999999999993576	-6.42440977391415e-12	17	0	0	33	6908
ko00785	Lipoic acid metabolism	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
hsa00780	Biotin metabolism	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
ko01220	Degradation of aromatic compounds	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
hsa01220	Degradation of aromatic compounds	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
hsa00785	Lipoic acid metabolism	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
ko00780	Biotin metabolism	0.999999999993866	-6.13383930721225e-12	3	0	0	33	6908
hsa03030	DNA replication	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
ko03030	DNA replication	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
hsa05340	Primary immunodeficiency	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
ko00040	Pentose and glucuronate interconversions	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
hsa00040	Pentose and glucuronate interconversions	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
ko05340	Primary immunodeficiency	0.999999999994346	-5.65355290836643e-12	36	0	0	33	6908
hsa04530	Tight junction	0.999999999994657	-5.3427457325879e-12	138	0	0	33	6908
ko04530	Tight junction	0.999999999994657	-5.3427457325879e-12	138	0	0	33	6908
ko04668	TNF signaling pathway	0.99999999999477	-5.22984603703599e-12	110	0	0	33	6908
hsa04668	TNF signaling pathway	0.99999999999477	-5.22984603703599e-12	110	0	0	33	6908
ko04144	Endocytosis	0.999999999994832	-5.16779204492025e-12	258	0	0	33	6908
hsa04144	Endocytosis	0.999999999994832	-5.16779204492025e-12	258	0	0	33	6908
hsa00280	Valine, leucine and isoleucine degradation	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
ko04672	Intestinal immune network for IgA production	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
ko04961	Endocrine and other factor-regulated calcium reabsorption	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
hsa04672	Intestinal immune network for IgA production	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
ko00600	Sphingolipid metabolism	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
hsa03420	Nucleotide excision repair	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
ko00280	Valine, leucine and isoleucine degradation	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
hsa00600	Sphingolipid metabolism	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
ko03420	Nucleotide excision repair	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
hsa04961	Endocrine and other factor-regulated calcium reabsorption	0.999999999994927	-5.07303776024779e-12	47	0	0	33	6908
hsa00472	D-Arginine and D-ornithine metabolism	0.999999999994971	-5.02939703772576e-12	1	0	0	33	6908
ko00472	D-Arginine and D-ornithine metabolism	0.999999999994971	-5.02939703772576e-12	1	0	0	33	6908
ko04742	Taste transduction	0.99999999999498	-5.01975744687202e-12	51	0	0	33	6908
hsa00480	Glutathione metabolism	0.99999999999498	-5.01975744687202e-12	51	0	0	33	6908
hsa04742	Taste transduction	0.99999999999498	-5.01975744687202e-12	51	0	0	33	6908
ko00480	Glutathione metabolism	0.99999999999498	-5.01975744687202e-12	51	0	0	33	6908
hsa05140	Leishmaniasis	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
ko05140	Leishmaniasis	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
hsa04662	B cell receptor signaling pathway	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
hsa04917	Prolactin signaling pathway	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
ko04917	Prolactin signaling pathway	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
ko04662	B cell receptor signaling pathway	0.999999999995215	-4.78454236999194e-12	72	0	0	33	6908
ko04145	Phagosome	0.999999999995434	-4.56566743770088e-12	152	0	0	33	6908
hsa04145	Phagosome	0.999999999995434	-4.56566743770088e-12	152	0	0	33	6908
hsa00531	Glycosaminoglycan degradation	0.999999999995591	-4.40890384749685e-12	19	0	0	33	6908
ko00531	Glycosaminoglycan degradation	0.999999999995591	-4.40890384749685e-12	19	0	0	33	6908
hsa03460	Fanconi anemia pathway	0.999999999995751	-4.24921406932438e-12	53	0	0	33	6908
ko05110	Vibrio cholerae infection	0.999999999995751	-4.24921406932438e-12	53	0	0	33	6908
hsa05110	Vibrio cholerae infection	0.999999999995751	-4.24921406932438e-12	53	0	0	33	6908
ko03460	Fanconi anemia pathway	0.999999999995751	-4.24921406932438e-12	53	0	0	33	6908
ko00520	Amino sugar and nucleotide sugar metabolism	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
ko04330	Notch signaling pathway	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
hsa01212	Fatty acid metabolism	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
hsa00520	Amino sugar and nucleotide sugar metabolism	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
ko01212	Fatty acid metabolism	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
ko04930	Type II diabetes mellitus	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
hsa04330	Notch signaling pathway	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
hsa04930	Type II diabetes mellitus	0.99999999999584	-4.16040816758277e-12	48	0	0	33	6908
hsa04910	Insulin signaling pathway	0.999999999995857	-4.14310842359451e-12	139	0	0	33	6908
ko04910	Insulin signaling pathway	0.999999999995857	-4.14310842359451e-12	139	0	0	33	6908
hsa00340	Histidine metabolism	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
hsa04964	Proximal tubule bicarbonate reclamation	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
hsa03060	Protein export	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko03430	Mismatch repair	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko03060	Protein export	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko01040	Biosynthesis of unsaturated fatty acids	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko04964	Proximal tubule bicarbonate reclamation	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
hsa04614	Renin-angiotensin system	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko04614	Renin-angiotensin system	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
hsa01040	Biosynthesis of unsaturated fatty acids	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
hsa03430	Mismatch repair	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko00340	Histidine metabolism	0.999999999995887	-4.11256707303452e-12	23	0	0	33	6908
ko00051	Fructose and mannose metabolism	0.999999999996071	-3.92848434962857e-12	32	0	0	33	6908
hsa00051	Fructose and mannose metabolism	0.999999999996071	-3.92848434962857e-12	32	0	0	33	6908
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999996348	-3.65225112169025e-12	24	0	0	33	6908
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999996348	-3.65225112169025e-12	24	0	0	33	6908
hsa04977	Vitamin digestion and absorption	0.999999999996348	-3.65225112169025e-12	24	0	0	33	6908
ko04977	Vitamin digestion and absorption	0.999999999996348	-3.65225112169025e-12	24	0	0	33	6908
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	0.999999999996608	-3.3920468605231e-12	15	0	0	33	6908
hsa00604	Glycosphingolipid biosynthesis - ganglio series	0.999999999996608	-3.3920468605231e-12	15	0	0	33	6908
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	0.999999999996608	-3.3920468605231e-12	15	0	0	33	6908
ko00604	Glycosphingolipid biosynthesis - ganglio series	0.999999999996608	-3.3920468605231e-12	15	0	0	33	6908
hsa04146	Peroxisome	0.999999999996637	-3.36331368919055e-12	83	0	0	33	6908
ko04146	Peroxisome	0.999999999996637	-3.36331368919055e-12	83	0	0	33	6908
ko04660	T cell receptor signaling pathway	0.999999999996946	-3.05432207657328e-12	104	0	0	33	6908
hsa05142	Chagas disease (American trypanosomiasis)	0.999999999996946	-3.05432207657328e-12	104	0	0	33	6908
ko05142	Chagas disease (American trypanosomiasis)	0.999999999996946	-3.05432207657328e-12	104	0	0	33	6908
hsa04660	T cell receptor signaling pathway	0.999999999996946	-3.05432207657328e-12	104	0	0	33	6908
hsa04976	Bile secretion	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
ko04976	Bile secretion	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
hsa00562	Inositol phosphate metabolism	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
ko00562	Inositol phosphate metabolism	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
hsa04918	Thyroid hormone synthesis	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
ko04918	Thyroid hormone synthesis	0.99999999999714	-2.85973294761973e-12	71	0	0	33	6908
hsa03008	Ribosome biogenesis in eukaryotes	0.999999999997349	-2.6514647633959e-12	78	0	0	33	6908
hsa05100	Bacterial invasion of epithelial cells	0.999999999997349	-2.6514647633959e-12	78	0	0	33	6908
ko03008	Ribosome biogenesis in eukaryotes	0.999999999997349	-2.6514647633959e-12	78	0	0	33	6908
ko05100	Bacterial invasion of epithelial cells	0.999999999997349	-2.6514647633959e-12	78	0	0	33	6908
hsa04611	Platelet activation	0.999999999997494	-2.50599491863615e-12	130	0	0	33	6908
ko05210	Colorectal cancer	0.999999999997669	-2.33133374492633e-12	62	0	0	33	6908
hsa00590	Arachidonic acid metabolism	0.999999999997669	-2.33133374492633e-12	62	0	0	33	6908
hsa05210	Colorectal cancer	0.999999999997669	-2.33133374492633e-12	62	0	0	33	6908
ko00590	Arachidonic acid metabolism	0.999999999997669	-2.33133374492633e-12	62	0	0	33	6908
hsa04621	NOD-like receptor signaling pathway	0.999999999997693	-2.307175586959e-12	57	0	0	33	6908
hsa05221	Acute myeloid leukemia	0.999999999997693	-2.307175586959e-12	57	0	0	33	6908
ko05221	Acute myeloid leukemia	0.999999999997693	-2.307175586959e-12	57	0	0	33	6908
ko04621	NOD-like receptor signaling pathway	0.999999999997693	-2.307175586959e-12	57	0	0	33	6908
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	0.99999999999808	-1.91959548339169e-12	11	0	0	33	6908
hsa00430	Taurine and hypotaurine metabolism	0.99999999999808	-1.91959548339169e-12	11	0	0	33	6908
hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	0.99999999999808	-1.91959548339169e-12	11	0	0	33	6908
ko00430	Taurine and hypotaurine metabolism	0.99999999999808	-1.91959548339169e-12	11	0	0	33	6908
ko04514	Cell adhesion molecules (CAMs)	0.999999999998683	-1.31700602114279e-12	142	0	0	33	6908
hsa04514	Cell adhesion molecules (CAMs)	0.999999999998683	-1.31700602114279e-12	142	0	0	33	6908
hsa00983	Drug metabolism - other enzymes	0.999999999998866	-1.1344389578458e-12	46	0	0	33	6908
ko00983	Drug metabolism - other enzymes	0.999999999998866	-1.1344389578458e-12	46	0	0	33	6908
ko04970	Salivary secretion	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
hsa05323	Rheumatoid arthritis	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
hsa04974	Protein digestion and absorption	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
ko04974	Protein digestion and absorption	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
ko05323	Rheumatoid arthritis	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
hsa05215	Prostate cancer	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
ko05215	Prostate cancer	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
hsa04970	Salivary secretion	0.999999999998924	-1.07604120609275e-12	89	0	0	33	6908
ko04350	TGF-beta signaling pathway	0.999999999999016	-9.84138439999938e-13	84	0	0	33	6908
hsa04350	TGF-beta signaling pathway	0.999999999999016	-9.84138439999938e-13	84	0	0	33	6908
ko00010	Glycolysis / Gluconeogenesis	0.999999999999132	-8.6770423667093e-13	67	0	0	33	6908
hsa00010	Glycolysis / Gluconeogenesis	0.999999999999132	-8.6770423667093e-13	67	0	0	33	6908
ko05230	Central carbon metabolism in cancer	0.999999999999132	-8.6770423667093e-13	67	0	0	33	6908
hsa05230	Central carbon metabolism in cancer	0.999999999999132	-8.6770423667093e-13	67	0	0	33	6908
hsa00670	One carbon pool by folate	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
hsa00100	Steroid biosynthesis	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
ko00220	Arginine biosynthesis	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
hsa00220	Arginine biosynthesis	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
ko00670	One carbon pool by folate	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
ko00100	Steroid biosynthesis	0.99999999999928	-7.20160225225712e-13	20	0	0	33	6908
ko04080	Neuroactive ligand-receptor interaction	0.999999999999301	-6.98825640402485e-13	276	0	0	33	6908
hsa04080	Neuroactive ligand-receptor interaction	0.999999999999301	-6.98825640402485e-13	276	0	0	33	6908
ko03015	mRNA surveillance pathway	0.999999999999985	-1.45784134591181e-14	91	0	0	33	6908
hsa04064	NF-kappa B signaling pathway	0.999999999999985	-1.45784134591181e-14	91	0	0	33	6908
hsa03015	mRNA surveillance pathway	0.999999999999985	-1.45784134591181e-14	91	0	0	33	6908
hsa04931	Insulin resistance	1.00000000000022	2.21474258001405e-13	111	0	0	33	6908
hsa05203	Viral carcinogenesis	1.00000000000057	5.72484533615533e-13	205	0	0	33	6908
ko05203	Viral carcinogenesis	1.00000000000057	5.72484533615533e-13	205	0	0	33	6908
hsa05322	Systemic lupus erythematosus	1.00000000000099	9.86069238943208e-13	134	0	0	33	6908
ko05162	Measles	1.00000000000099	9.86069238943208e-13	134	0	0	33	6908
hsa05162	Measles	1.00000000000099	9.86069238943208e-13	134	0	0	33	6908
hsa04068	FoxO signaling pathway	1.00000000000099	9.86069238943208e-13	134	0	0	33	6908
ko05322	Systemic lupus erythematosus	1.00000000000099	9.86069238943208e-13	134	0	0	33	6908
hsa00750	Vitamin B6 metabolism	1.00000000000122	1.22481923431254e-12	6	0	0	33	6908
ko00750	Vitamin B6 metabolism	1.00000000000122	1.22481923431254e-12	6	0	0	33	6908
hsa00830	Retinol metabolism	1.00000000000124	1.24393877669484e-12	65	0	0	33	6908
ko05321	Inflammatory bowel disease (IBD)	1.00000000000124	1.24393877669484e-12	65	0	0	33	6908
ko00830	Retinol metabolism	1.00000000000124	1.24393877669484e-12	65	0	0	33	6908
hsa05321	Inflammatory bowel disease (IBD)	1.00000000000124	1.24393877669484e-12	65	0	0	33	6908
hsa04623	Cytosolic DNA-sensing pathway	1.00000000000194	1.94251887729806e-12	63	0	0	33	6908
ko04623	Cytosolic DNA-sensing pathway	1.00000000000194	1.94251887729806e-12	63	0	0	33	6908
hsa04664	Fc epsilon RI signaling pathway	1.00000000000201	2.0102426083168e-12	70	0	0	33	6908
ko04920	Adipocytokine signaling pathway	1.00000000000201	2.0102426083168e-12	70	0	0	33	6908
ko04664	Fc epsilon RI signaling pathway	1.00000000000201	2.0102426083168e-12	70	0	0	33	6908
hsa04920	Adipocytokine signaling pathway	1.00000000000201	2.0102426083168e-12	70	0	0	33	6908
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1.00000000000212	2.12008340160257e-12	68	0	0	33	6908
ko00982	Drug metabolism - cytochrome P450	1.00000000000212	2.12008340160257e-12	68	0	0	33	6908
hsa00982	Drug metabolism - cytochrome P450	1.00000000000212	2.12008340160257e-12	68	0	0	33	6908
ko05120	Epithelial cell signaling in Helicobacter pylori infection	1.00000000000212	2.12008340160257e-12	68	0	0	33	6908
ko05168	Herpes simplex infection	1.00000000000227	2.26582397543683e-12	184	0	0	33	6908
hsa05168	Herpes simplex infection	1.00000000000227	2.26582397543683e-12	184	0	0	33	6908
ko04630	Jak-STAT signaling pathway	1.00000000000249	2.48644560897954e-12	158	0	0	33	6908
hsa04630	Jak-STAT signaling pathway	1.00000000000249	2.48644560897954e-12	158	0	0	33	6908
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1.0000000000028	2.79608698404786e-12	147	0	0	33	6908
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	1.0000000000028	2.79608698404786e-12	147	0	0	33	6908
hsa04914	Progesterone-mediated oocyte maturation	1.00000000000298	2.97929555061848e-12	87	0	0	33	6908
ko04914	Progesterone-mediated oocyte maturation	1.00000000000298	2.97929555061848e-12	87	0	0	33	6908
hsa05204	Chemical carcinogenesis	1.00000000000311	3.10901973996656e-12	81	0	0	33	6908
ko05204	Chemical carcinogenesis	1.00000000000311	3.10901973996656e-12	81	0	0	33	6908
ko03013	RNA transport	1.00000000000312	3.12122717203924e-12	166	0	0	33	6908
hsa03013	RNA transport	1.00000000000312	3.12122717203924e-12	166	0	0	33	6908
ko05211	Renal cell carcinoma	1.00000000000318	3.1836441070275e-12	66	0	0	33	6908
ko05212	Pancreatic cancer	1.00000000000318	3.1836441070275e-12	66	0	0	33	6908
hsa05212	Pancreatic cancer	1.00000000000318	3.1836441070275e-12	66	0	0	33	6908
hsa05211	Renal cell carcinoma	1.00000000000318	3.1836441070275e-12	66	0	0	33	6908
hsa04142	Lysosome	1.0000000000046	4.60417405403424e-12	123	0	0	33	6908
ko04142	Lysosome	1.0000000000046	4.60417405403424e-12	123	0	0	33	6908
ko04320	Dorso-ventral axis formation	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
hsa00053	Ascorbate and aldarate metabolism	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
ko00053	Ascorbate and aldarate metabolism	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
hsa04320	Dorso-ventral axis formation	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
hsa00650	Butanoate metabolism	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
ko00650	Butanoate metabolism	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
ko04966	Collecting duct acid secretion	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
hsa04966	Collecting duct acid secretion	1.00000000000506	5.05999793869138e-12	27	0	0	33	6908
hsa04122	Sulfur relay system	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
ko00920	Sulfur metabolism	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
hsa00072	Synthesis and degradation of ketone bodies	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
ko04122	Sulfur relay system	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
hsa00920	Sulfur metabolism	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
ko00072	Synthesis and degradation of ketone bodies	1.00000000000511	5.10930096375104e-12	10	0	0	33	6908
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000538	5.38287447969895e-12	26	0	0	33	6908
hsa04950	Maturity onset diabetes of the young	1.00000000000538	5.38287447969895e-12	26	0	0	33	6908
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000538	5.38287447969895e-12	26	0	0	33	6908
ko04950	Maturity onset diabetes of the young	1.00000000000538	5.38287447969895e-12	26	0	0	33	6908
ko04520	Adherens junction	1.00000000000816	8.16446519586829e-12	73	0	0	33	6908
hsa04520	Adherens junction	1.00000000000816	8.16446519586829e-12	73	0	0	33	6908
hsa05220	Chronic myeloid leukemia	1.00000000000816	8.16446519586829e-12	73	0	0	33	6908
ko05220	Chronic myeloid leukemia	1.00000000000816	8.16446519586829e-12	73	0	0	33	6908
